公司资料
TransMedics 股价、新闻与催化剂
- 股票代码:
- TMDX
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
88.35 USD (-0.26%)
收盘价
最后更新: 2026年8月17日
2.37B USD
市值
股价为何变动
As of Aug 17, 2026, TMDX closed down 0.26% at $88.35. No new same-company headline was identified in the current news window.
公司概览
业务概览
TransMedics is a transplant technology company focused on organ transport, preservation, and perfusion systems.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, TransMedics sits in specialized medical devices.
商业模式特征
The company generates revenue through transplant logistics, device usage, and the expansion of its organ-management platform.
生物医药行业定位
TransMedics is a procedure-driven medtech name whose valuation is tied to adoption in the transplant workflow.
未来催化剂
- TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint. The market will care about whether the platform keeps winning more procedures and more centers.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。